Position in HROW
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,650,912
+$12,933,392 QoQ
Shares Held
439,155
+270.1% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#11
of 223 holders
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Derivatives in HROW
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
0
PutValue
$1,323,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Divisadero Street Capital Management, LP holds $252,142,880 across 4 Drug Manufacturers - Specialty & Generic names. HROW ranks #3 (7.4% of the industry book) .
All Filings in HROW
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,650,912 | 439,155 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $5,717,520 | 118,670 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,293,007 | 140,570 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $1,623,415 | 36,108 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $1,323,000 | 100,000 | Put | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||